AtriCure, Inc. (ATRC) stock
ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30929% above fair value
$54.11−1.34 (-2.42%)
Close on Nov 19, 2026Market cap $2.75BP/E 257.7Yield –
AtriCure shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
AtriCure's shares outstanding was 49M at Jun 30, 2026. For fiscal 2025 it was 48M, up 1.7% from the year before. Over ten years it grew 5.5% a year on average. The highest annual figure on record is 48M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 48M | +1.7% |
| FY2024 | Dec 31, 2024 | 47M | +1.4% |
| FY2023 | Dec 31, 2023 | 46M | +1.2% |
| FY2022 | Dec 31, 2022 | 46M | -0.6% |
| FY2021 | Dec 31, 2021 | 46M | +9.3% |
| FY2020 | Dec 31, 2020 | 42M | +12.1% |
| FY2019 | Dec 31, 2019 | 38M | +10.3% |
| FY2018 | Dec 31, 2018 | 34M | +5.2% |
| FY2017 | Dec 31, 2017 | 32M | +2.5% |
| FY2016 | Dec 31, 2016 | 32M | +12.7% |
| FY2015 | Dec 31, 2015 | 28M | +6.4% |
| FY2014 | Dec 31, 2014 | 26M | +29.1% |
| FY2013 | Dec 31, 2013 | 20M | +26.2% |
| FY2012 | Dec 31, 2012 | 16M | +3.3% |
| FY2011 | Dec 31, 2011 | 16M | +3.8% |
| FY2010 | Dec 31, 2010 | 15M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 49M | +2.4% |
| Q1 FY2026 | Mar 31, 2026 | 49M | +3.5% |
| Q4 FY2025 | Dec 31, 2025 | 48M | +1.8% |
| Q3 FY2025 | Sep 30, 2025 | 48M | +1.7% |
| Q2 FY2025 | Jun 30, 2025 | 48M | +1.7% |
| Q1 FY2025 | Mar 31, 2025 | 47M | +1.4% |
| Q4 FY2024 | Dec 31, 2024 | 47M | +1.5% |
| Q3 FY2024 | Sep 30, 2024 | 47M | +1.5% |
| Q2 FY2024 | Jun 30, 2024 | 47M | +1.4% |
| Q1 FY2024 | Mar 31, 2024 | 47M | +1.3% |
| Q4 FY2023 | Dec 31, 2023 | 46M | +1.2% |
| Q3 FY2023 | Sep 30, 2023 | 46M | +1.3% |
| Q2 FY2023 | Jun 30, 2023 | 46M | +1.3% |
| Q1 FY2023 | Mar 31, 2023 | 46M | +1.3% |
| Q4 FY2022 | Dec 31, 2022 | 46M | -0.6% |
| Q3 FY2022 | Sep 30, 2022 | 46M | -0.6% |
| Q2 FY2022 | Jun 30, 2022 | 46M | +1.5% |
| Q1 FY2022 | Mar 31, 2022 | 46M | +2.0% |
| Q4 FY2021 | Dec 31, 2021 | 46M | +4.5% |
| Q3 FY2021 | Sep 30, 2021 | 46M | +4.7% |
| Q2 FY2021 | Jun 30, 2021 | 45M | +8.1% |
| Q1 FY2021 | Mar 31, 2021 | 45M | +15.4% |
| Q4 FY2020 | Dec 31, 2020 | 44M | +15.7% |
| Q3 FY2020 | Sep 30, 2020 | 44M | +16.3% |
| Q2 FY2020 | Jun 30, 2020 | 42M | +11.6% |
| Q1 FY2020 | Mar 31, 2020 | 39M | +4.6% |
| Q4 FY2019 | Dec 31, 2019 | 38M | +4.6% |
| Q3 FY2019 | Sep 30, 2019 | 38M | +12.6% |
| Q2 FY2019 | Jun 30, 2019 | 37M | +12.3% |
| Q1 FY2019 | Mar 31, 2019 | 37M | +12.3% |
| Q4 FY2018 | Dec 31, 2018 | 37M | +11.8% |
| Q3 FY2018 | Sep 30, 2018 | 34M | +3.1% |
| Q2 FY2018 | Jun 30, 2018 | 33M | +3.0% |
| Q1 FY2018 | Mar 31, 2018 | 33M | +2.8% |
| Q4 FY2017 | Dec 31, 2017 | 33M | +2.7% |
| Q3 FY2017 | Sep 30, 2017 | 33M | +2.7% |
| Q2 FY2017 | Jun 30, 2017 | 32M | – |
| Q1 FY2017 | Mar 31, 2017 | 32M | – |
| Q4 FY2016 | Dec 31, 2016 | 32M | – |
| Q3 FY2016 | Sep 30, 2016 | 32M | – |
See a number that looks wrong?